BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12147092)

  • 1. Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region.
    Putti TC; To KF; Hsu HC; Chan AT; Lai GM; Tse G; Lee YS; Whang-Peng J; Millward M; Lin L; Lin X; Lee CS
    Histopathology; 2002 Aug; 41(2):144-51. PubMed ID: 12147092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
    Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
    World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma.
    Zafar M; Hashmi SN; Faisal MJ; Ahmed R; Ali SS
    J Coll Physicians Surg Pak; 2017 Apr; 27(4):209-212. PubMed ID: 28492148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
    Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
    Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemistry study of EGFR expression in head and neck squamous cell carcinoma].
    Altuna Mariezkurrena X; Algaba Guimerá J; Wang Rodríguez J; Weisman R; Ongkeko W
    Acta Otorrinolaringol Esp; 2005 Apr; 56(4):143-6. PubMed ID: 15871288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
    Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
    Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
    Bădulescu F; Bădulescu A; Crişan A; Popescu FC
    Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistological studies on growth potential of head and neck carcinomas].
    Nin F
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Mar; 101(3):312-26. PubMed ID: 9584471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.
    Watson RF; Chernock RD; Zhang KH; Michel LS; Adkins DR; El-Mofty SK; Lewis JS
    Head Neck Pathol; 2015 Sep; 9(3):360-8. PubMed ID: 25563452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
    Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
    Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
    Ansell A; Jedlinski A; Johansson AC; Roberg K
    J Oral Pathol Med; 2016 Jan; 45(1):9-16. PubMed ID: 25677871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epidermal growth factor receptor 2 neu expression in head and neck squamous cell cancers and its clinicopathological correlation: Results from an Indian cancer center.
    Vats S; Ganesh MS; Agarwal A
    Indian J Pathol Microbiol; 2018; 61(3):313-318. PubMed ID: 30004046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal Growth Factor Receptor (EGFR) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of Head and Neck Squamous Cell Carcinomas.
    Cimpean AM; Balica RA; Doros IC; Balica NC; Gaje PN; Popovici RA; Raica M
    Cancer Genomics Proteomics; 2016; 13(1):75-81. PubMed ID: 26708602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
    Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
    Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas.
    Yuen PW; Man M; Lam KY; Kwong YL
    J Clin Pathol; 2002 Jan; 55(1):58-60. PubMed ID: 11825926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
    Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
    Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma.
    Pectasides E; Rampias T; Kountourakis P; Sasaki C; Kowalski D; Fountzilas G; Zaramboukas T; Rimm D; Burtness B; Psyrri A
    Clin Cancer Res; 2011 May; 17(9):2947-54. PubMed ID: 21355076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.